Published in Am J Physiol Lung Cell Mol Physiol on February 28, 2014
Caveolin-1 regulates chemokine receptor 5-mediated contribution of bone marrow-derived cells to dermal fibrosis. Front Pharmacol (2014) 0.86
Fibrocytes in the fibrotic lung: altered phenotype detected by flow cytometry. Front Pharmacol (2014) 0.83
Fasudil, an inhibitor of Rho-associated coiled-coil kinase, attenuates hyperoxia-induced pulmonary fibrosis in neonatal rats. Int J Clin Exp Pathol (2015) 0.81
Update on scleroderma-associated interstitial lung disease. Curr Opin Rheumatol (2014) 0.80
The Living Scar - Cardiac Fibroblasts and the Injured Heart. Trends Mol Med (2016) 0.80
A modified murine model of systemic sclerosis: bleomycin given by pump infusion induced skin and pulmonary inflammation and fibrosis. Lab Invest (2014) 0.79
Enhanced chemokine-receptor expression, function, and signaling in healthy African American and scleroderma-patient monocytes are regulated by caveolin-1. Fibrogenesis Tissue Repair (2015) 0.77
17(R)-resolvin D1 ameliorates bleomycin-induced pulmonary fibrosis in mice. Physiol Rep (2015) 0.76
Deficient Adipogenesis of Scleroderma Patient and Healthy African American Monocytes. Front Pharmacol (2017) 0.75
Knockout of endothelin type B receptor signaling attenuates bleomycin-induced skin sclerosis in mice. Arthritis Res Ther (2016) 0.75
Animal models of systemic sclerosis: their utility and limitations. Open Access Rheumatol (2014) 0.75
Reversal of maladaptive fibrosis and compromised ventricular function in the pressure overloaded heart by a caveolin-1 surrogate peptide. Lab Invest (2017) 0.75
Murine models of pulmonary fibrosis. Am J Physiol Lung Cell Mol Physiol (2007) 5.92
Idiopathic pulmonary fibrosis. Lancet (2011) 5.25
The bleomycin animal model: a useful tool to investigate treatment options for idiopathic pulmonary fibrosis? Int J Biochem Cell Biol (2007) 3.33
Pulmonary fibrosis: pathogenesis, etiology and regulation. Mucosal Immunol (2009) 3.13
Repetitive intratracheal bleomycin models several features of idiopathic pulmonary fibrosis. Am J Physiol Lung Cell Mol Physiol (2010) 2.53
Pulmonary fibrosis: searching for model answers. Am J Respir Cell Mol Biol (2005) 2.05
Antifibrotic properties of caveolin-1 scaffolding domain in vitro and in vivo. Am J Physiol Lung Cell Mol Physiol (2008) 1.68
Interstitial lung disease in connective tissue disorders. Lancet (2012) 1.67
Surfactant protein-D regulates effector cell function and fibrotic lung remodeling in response to bleomycin injury. Am J Respir Crit Care Med (2011) 1.66
Hsp47: a collagen-specific molecular chaperone. Trends Biochem Sci (1996) 1.61
Standardized quantification of pulmonary fibrosis in histological samples. Biotechniques (2008) 1.61
Modeling pulmonary fibrosis with bleomycin. Curr Opin Pulm Med (2011) 1.51
Studies on bleomycin. Cancer (1967) 1.49
Diagnostic assessment of patients with interstitial lung disease. Prim Care Respir J (2011) 1.41
High dose continuous infusion of bleomycin in mice: a new model for drug-induced pulmonary fibrosis. J Pharmacol Exp Ther (1987) 1.39
HSP47 as a collagen-specific molecular chaperone: function and expression in normal mouse development. Semin Cell Dev Biol (2003) 1.39
Chemistry and mechanism of action of bleomycin. Fed Proc (1974) 1.38
Progress toward improving animal models for idiopathic pulmonary fibrosis. Am J Med Sci (2011) 1.19
The collagen-specific molecular chaperone HSP47: is there a role in fibrosis? Trends Mol Med (2006) 1.18
Biological studies on bleomycin A. J Antibiot (Tokyo) (1967) 1.18
Idiopathic pulmonary fibrosis-an epidemiological and pathological review. Clin Rev Allergy Immunol (2011) 1.09
Caveolin-1 regulates leucocyte behaviour in fibrotic lung disease. Ann Rheum Dis (2010) 1.07
Hsp47 as a collagen-specific molecular chaperone. Methods Enzymol (2011) 1.02
Bleomycin induces pleural and subpleural fibrosis in the presence of carbon particles. Eur Respir J (2009) 1.02
Pulmonary toxicity of antitumor agents. Cancer Treat Rev (1983) 1.00
Bleomycin revisited: towards a more representative model of IPF? Am J Physiol Lung Cell Mol Physiol (2010) 0.94
Advances in understanding of idiopathic pulmonary fibrosis. Chin Med J (Engl) (2009) 0.81
Recent advances in the diagnosis and treatment of interstitial lung disease in systemic sclerosis (scleroderma): a review. Clin Exp Rheumatol (2011) 0.81
Update in diffuse parenchymal lung disease 2010. Am J Respir Crit Care Med (2011) 0.78
2013 classification criteria for systemic sclerosis: an American College of Rheumatology/European League against Rheumatism collaborative initiative. Arthritis Rheum (2013) 5.99
Periostin regulates collagen fibrillogenesis and the biomechanical properties of connective tissues. J Cell Biochem (2007) 3.53
2013 classification criteria for systemic sclerosis: an American college of rheumatology/European league against rheumatism collaborative initiative. Ann Rheum Dis (2013) 3.11
Effects of 1-year treatment with cyclophosphamide on outcomes at 2 years in scleroderma lung disease. Am J Respir Crit Care Med (2007) 2.86
Organ printing: tissue spheroids as building blocks. Biomaterials (2009) 2.43
Bronchoalveolar lavage and response to cyclophosphamide in scleroderma interstitial lung disease. Am J Respir Crit Care Med (2007) 2.41
Periostin promotes atrioventricular mesenchyme matrix invasion and remodeling mediated by integrin signaling through Rho/PI 3-kinase. Dev Biol (2006) 2.08
Umbilical cord mesenchymal stem cell transplantation in severe and refractory systemic lupus erythematosus. Arthritis Rheum (2010) 1.98
Limitations to the 6-minute walk test in interstitial lung disease and pulmonary hypertension in scleroderma. J Rheumatol (2009) 1.78
Periostin is expressed within the developing teeth at the sites of epithelial-mesenchymal interaction. Dev Dyn (2004) 1.72
Antifibrotic properties of caveolin-1 scaffolding domain in vitro and in vivo. Am J Physiol Lung Cell Mol Physiol (2008) 1.68
Demographic and clinical factors associated with in-hospital death among patients with systemic sclerosis. J Rheumatol (2005) 1.67
Effect of a multi-faceted intervention on gingival health among adults with systemic sclerosis. Clin Exp Rheumatol (2011) 1.61
Persistent down-regulation of Fli1, a suppressor of collagen transcription, in fibrotic scleroderma skin. Am J Pathol (2003) 1.57
QuantiFERON TB gold testing for tuberculosis screening in an inflammatory bowel disease cohort in the United States. Inflamm Bowel Dis (2011) 1.55
Allogeneic mesenchymal stem cell transplantation in severe and refractory systemic lupus erythematosus: 4 years of experience. Cell Transplant (2013) 1.53
Periostin regulates atrioventricular valve maturation. Dev Biol (2008) 1.49
Preserved musical semantic memory in semantic dementia. Arch Neurol (2011) 1.48
Hematopoietic origins of fibroblasts: II. In vitro studies of fibroblasts, CFU-F, and fibrocytes. Exp Hematol (2006) 1.45
Opposing effects of protein kinase Calpha and protein kinase Cepsilon on collagen expression by human lung fibroblasts are mediated via MEK/ERK and caveolin-1 signaling. J Biol Chem (2005) 1.44
Correlation of the degree of dyspnea with health-related quality of life, functional abilities, and diffusing capacity for carbon monoxide in patients with systemic sclerosis and active alveolitis: results from the Scleroderma Lung Study. Arthritis Rheum (2005) 1.42
HP1 proteins are essential for a dynamic nuclear response that rescues the function of perturbed heterochromatin in primary human cells. Mol Cell Biol (2006) 1.40
Altered monocyte and fibrocyte phenotype and function in scleroderma interstitial lung disease: reversal by caveolin-1 scaffolding domain peptide. Fibrogenesis Tissue Repair (2011) 1.26
Versican proteolysis mediates myocardial regression during outflow tract development. Dev Dyn (2007) 1.24
Emergency department performance measures and benchmarking summit. Acad Emerg Med (2006) 1.19
Enzyme-linked immunosorbent assay for detection of anti-RNA polymerase III antibody: analytical accuracy and clinical associations in systemic sclerosis. Arthritis Rheum (2005) 1.18
Through-focus scanning-optical-microscope imaging method for nanoscale dimensional analysis. Opt Lett (2008) 1.18
BMP-2 induces cell migration and periostin expression during atrioventricular valvulogenesis. Dev Biol (2007) 1.17
Scleroderma lung study (SLS): differences in the presentation and course of patients with limited versus diffuse systemic sclerosis. Ann Rheum Dis (2007) 1.15
Cartilage link protein 1 (Crtl1), an extracellular matrix component playing an important role in heart development. Dev Biol (2007) 1.15
The many facets of the matricelluar protein periostin during cardiac development, remodeling, and pathophysiology. J Cell Commun Signal (2009) 1.15
Systemic sclerosis-associated interstitial lung disease-proposed recommendations for future randomized clinical trials. Clin Exp Rheumatol (2010) 1.15
Hematopoietic origins of fibroblasts: I. In vivo studies of fibroblasts associated with solid tumors. Exp Hematol (2006) 1.15
Dabigatran, a direct thrombin inhibitor, demonstrates antifibrotic effects on lung fibroblasts. Arthritis Rheum (2009) 1.14
Immunolocalization of chick periostin protein in the developing heart. Anat Rec A Discov Mol Cell Evol Biol (2005) 1.12
Improving optical measurement uncertainty with combined multitool metrology using a Bayesian approach. Appl Opt (2012) 1.10
Correlates of depression, including overall and gastrointestinal functional status, among patients with systemic sclerosis. J Rheumatol (2005) 1.10
Anti-mitogenic effects of β-agonists and PGE2 on airway smooth muscle are PKA dependent. FASEB J (2010) 1.09
Antiinflammatory and antifibrotic effects of the oral direct thrombin inhibitor dabigatran etexilate in a murine model of interstitial lung disease. Arthritis Rheum (2011) 1.08
Distinct PKC isoforms mediate cell survival and DNA synthesis in thrombin-induced myofibroblasts. Am J Physiol Lung Cell Mol Physiol (2004) 1.07
Caveolin-1 regulates leucocyte behaviour in fibrotic lung disease. Ann Rheum Dis (2010) 1.07
Periostin promotes a fibroblastic lineage pathway in atrioventricular valve progenitor cells. Dev Dyn (2009) 1.07
Racial variation in clinical and immunological manifestations of systemic sclerosis. J Rheumatol (2006) 1.07
A chemical screen identifies novel compounds that overcome glial-mediated inhibition of neuronal regeneration. J Neurosci (2010) 1.05
Matrix metalloproteinase 2-integrin alpha(v)beta3 binding is required for mesenchymal cell invasive activity but not epithelial locomotion: a computational time-lapse study. Mol Biol Cell (2008) 1.05
Targeting hyaluronan interactions in malignant gliomas and their drug-resistant multipotent progenitors. Clin Cancer Res (2008) 1.04
The roles of low literacy and social support in predicting the preventability of hospital admission. J Gen Intern Med (2005) 1.04
Transplanted human cord blood cells give rise to hepatocytes in engrafted mice. Ann N Y Acad Sci (2003) 1.04
Contractile activity and smooth muscle alpha-actin organization in thrombin-induced human lung myofibroblasts. Am J Physiol Lung Cell Mol Physiol (2003) 1.03
PKC-dependent regulation of the receptor locus dominates functional consequences of cysteinyl leukotriene type 1 receptor activation. FASEB J (2007) 1.02
Atrioventricular valve development: new perspectives on an old theme. Differentiation (2012) 0.98
Apoptosis in the developing mouse heart. Dev Dyn (2006) 0.98
Hierarchical organization of scripts: converging evidence from FMRI and frontotemporal degeneration. Cereb Cortex (2010) 0.98
Evidence for Hox-specified positional identities in adult vasculature. BMC Dev Biol (2008) 0.98
Gastroesophageal reflux incites interstitial lung disease in systemic sclerosis: clinical, radiologic, histopathologic, and treatment evidence. Semin Arthritis Rheum (2010) 0.97
Down-regulation of collagen and connective tissue growth factor expression with hepatocyte growth factor in lung fibroblasts from white scleroderma patients via two signaling pathways. Arthritis Rheum (2007) 0.97
Acid ceramidase-mediated production of sphingosine 1-phosphate promotes prostate cancer invasion through upregulation of cathepsin B. Int J Cancer (2012) 0.96
Impairment of the antifibrotic effect of hepatocyte growth factor in lung fibroblasts from African Americans: possible role in systemic sclerosis. Arthritis Rheum (2007) 0.96
Surfactant protein D and KL-6 as serum biomarkers of interstitial lung disease in patients with scleroderma. J Rheumatol (2009) 0.96
Versican expression during skeletal/joint morphogenesis and patterning of muscle and nerve in the embryonic mouse limb. Anat Rec A Discov Mol Cell Evol Biol (2005) 0.95
Proteomic analysis of CTGF-activated lung fibroblasts: identification of IQGAP1 as a key player in lung fibroblast migration. Am J Physiol Lung Cell Mol Physiol (2008) 0.95
Curcumin-induced apoptosis in scleroderma lung fibroblasts: role of protein kinase cepsilon. Am J Respir Cell Mol Biol (2004) 0.95
Limb chondrogenesis is compromised in the versican deficient hdf mouse. Biochem Biophys Res Commun (2005) 0.95
Ethnic disparities among patients with pulmonary hypertension associated with systemic sclerosis. J Rheumatol (2007) 0.94
Pulmonary involvement in Sjögren syndrome. Clin Chest Med (2010) 0.94
Identifying new small molecule anti-invasive compounds for glioma treatment. Cell Cycle (2013) 0.94
ADAM-17 regulates endothelial cell morphology, proliferation, and in vitro angiogenesis. Biochem Biophys Res Commun (2009) 0.94
Neurological deficits during treatment with tumor necrosis factor-alpha antagonists. Am J Med Sci (2011) 0.93
Clinical aspects of lung involvement: lessons from idiopathic pulmonary fibrosis and the scleroderma lung study. Curr Rheumatol Rep (2005) 0.93
Recruitment of bone marrow-derived valve interstitial cells is a normal homeostatic process. J Mol Cell Cardiol (2011) 0.93
Activation of p53 with Nutlin-3a radiosensitizes lung cancer cells via enhancing radiation-induced premature senescence. Lung Cancer (2013) 0.93
Fourier domain optical tool normalization for quantitative parametric image reconstruction. Appl Opt (2013) 0.92
Ulnar artery involvement in systemic sclerosis (scleroderma). J Rheumatol (2002) 0.92
Effect of orofacial exercises on oral aperture in adults with systemic sclerosis. Disabil Rehabil (2011) 0.92
Chick embryos exposed to trichloroethylene in an ex ovo culture model show selective defects in early endocardial cushion tissue formation. Birth Defects Res A Clin Mol Teratol (2006) 0.90
New developments in scleroderma interstitial lung disease. Curr Opin Rheumatol (2005) 0.90
Periostin induces intracellular cross-talk between kinases and hyaluronan in atrioventricular valvulogenesis. J Biol Chem (2014) 0.88
On the role of shear stress in cardiogenesis. Endothelium (2006) 0.86
Rationale for anticoagulant therapy of pulmonary fibrosis. Am J Respir Crit Care Med (2014) 0.86
Secondary analysis of APPLE study suggests atorvastatin may reduce atherosclerosis progression in pubertal lupus patients with higher C reactive protein. Ann Rheum Dis (2013) 0.86
Changing topographic Hox expression in blood vessels results in regionally distinct vessel wall remodeling. Biol Open (2012) 0.85
3D printing facilitated scaffold-free tissue unit fabrication. Biofabrication (2014) 0.85
Opposing roles of two isoforms of the Prx1 homeobox gene in chondrogenesis. Dev Dyn (2005) 0.85
Versican expression during synovial joint morphogenesis. Int J Biol Sci (2007) 0.84
Detection and quantitation of curcumin in mouse lung cell cultures by matrix-assisted laser desorption ionization time of flight mass spectrometry. Anal Biochem (2005) 0.84
Patterns of hospital admissions and emergency room visits among patients with scleroderma in South Carolina, USA. J Rheumatol (2003) 0.83